Annual Review of Genetics' The Power of Human Cancer Genetics as Revealed by Pediatric Low-Grade Glioma
The PLGA Fund at Pediatric Brain Tumor Foundation Sponsors PLGG/PLGA Coalition Meeting in Germany
First Snapshots of Cancer Protein B-Raf Illuminate Basic Biology and Can Impact Drug Design for Pediatric Low Grade Glioma Brain Tumor Patients
Pediatric Brain Tumor Foundation Names Awardees of Early Career Development Research Grants
Pediatric Brain Tumor Foundation and American Association for Cancer Research Announce RFP for Research Grant to Optimize Drug Dosing Strategies for PLGA Patients
Study Results: New PLGA Research Demonstrates the Power of Teamwork in Improving Outcomes for Kids with Brain Tumors
Pediatric Brain Tumor Foundation and Partners Announce Investment in Novel Immunotherapy Research at the Chad Carr Pediatric Brain Tumor Center at Michigan Medicine
NCI-COG Pediatric MATCH Study Finds More Targetable Genetic Changes than Expected
Entrectinib, Roche’s New Precision Medicine Therapy, Shows Promise for Treating Pediatric Brain Tumors
Study Results: Immunotherapy Drug Shows Promise for Adult Glioblastoma Patients When Treated Before Surgery
Pediatric Brain Tumor Foundation Responds to State of the Union and the Need for More Government Funding for Childhood Cancer Research
Pediatric Brain Tumor Foundation Joins Other Members of Brain Tumor Funders’ Collaborative in Announcing $3 Million in Research Grants
Study Results: Liquid Biopsy Blood Test Shows Promise for Detecting Genetic Changes in Pediatric Brain Tumors
New Study: Radiation-associated Cognitive Decline Prevented in First Animal Model of Glioma
Pediatric Brain Tumor Foundation and A Kids’ Brain Tumor Cure Join Forces to Change the Outcome for All Children with Brain Cancer
New “Multi-Omic” Research Projects Launched to Confront the Complexity of Glioblastoma and Pediatric Brain Tumor Treatment Development
This week, the National Cancer Institute (NCI), the U.S. government’s principal agency for cancer research, announced funding for new adult and pediatric brain cancer research projects. The funding, totaling $4 million, was driven by the leadership of the NCI and concerted advocacy efforts of the U.S. brain tumor community, led by the Eliminate Cancer Initiative (ECI), the National Brain Tumor Society (NBTS), and the Pediatric Brain Tumor Foundation (PBTF).
Christopher Brandle Joy of Life Foundation and PBTF Partner Again to Fund Cutting-Edge Medulloblastoma Research
The Pediatric Brain Tumor Foundation (PBTF) has received a $150,000 grant from the Christopher Brandle Joy of Life Foundation (CBJOLF) to fund medulloblastoma research at Massachusetts General Hospital.
Phase 1b Clinical Trial for Genetically Modified Poliovirus Therapy Enrolling Children and Teens at Duke University
Researchers and Pediatric Brain Tumor Nonprofits Gather in Portland for 2018 Translating Discoveries to Cure the Kids
St. Jude Study Reveals Chronic Health Conditions Are Most Prevalent in Survivors of Pediatric Central Nervous System Cancers
A study by St. Jude has revealed that the extent of chronic health conditions in adult childhood cancer survivors is significantly more substantial than those in the general public. The results of this extensive research can be used to better inform future clinical guidelines, research investigations and health services planning for childhood cancer survivors.